Glycaemic Response Testing

This study has been completed.
Reading Scientific Services Ltd.
Information provided by (Responsible Party):
Mondelēz International, Inc. Identifier:
First received: February 16, 2012
Last updated: September 7, 2012
Last verified: September 2012
The purpose of this study is to assess whether added food ingredient(s) affect glycemic responses to a liquid meal tolerance test (LMTT).

Condition Intervention
Glycaemic Index
Glycaemic Response
Other: Dietary Intervention

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single Blind (Subject)
Primary Purpose: Basic Science
Official Title: Glycaemic Response Testing

Further study details as provided by Mondelēz International, Inc.:

Primary Outcome Measures:
  • Glycaemic index of experimental test food using capillary blood [ Time Frame: 0-120 minutes ] [ Designated as safety issue: No ]

Enrollment: 12
Study Start Date: December 2011
Study Completion Date: January 2012
Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Placebo Comparator: Control Test Drink
Control drink
Other: Dietary Intervention
300 ml of liquid food product
Experimental: Experimental Test Drink 1
Control drink containing ingredient 1
Other: Dietary Intervention
300 mL of liquid food product
Experimental: Experimental Test Drink 2
Control drink containing ingredient 2
Other: Dietary Intervention
300 ml of liquid food product


Ages Eligible for Study:   18 Years to 55 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Male or female (not less than 40% males or females
  • Non-smoker
  • Aged 18 to 55 years
  • Have a body mass index between 18.5 to 29.99 kg/m2
  • Healthy, non-diabetic, no gastric bypass surgery
  • Having a fasting plasma glucose (finger stick) <100 mg/dl (<5.5 mmol/L)
  • Willing and able to provide written informed consent
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01536847

Sponsors and Collaborators
Mondelēz International, Inc.
Reading Scientific Services Ltd.
Principal Investigator: Suzana Louth, Dr RSSL
  More Information

No publications provided

Responsible Party: Mondelēz International, Inc. Identifier: NCT01536847     History of Changes
Other Study ID Numbers: P11-09257
Study First Received: February 16, 2012
Last Updated: September 7, 2012
Health Authority: United Kingdom: Research Ethics Committee processed this record on November 25, 2015